Literature DB >> 18230947

Mitochondrial energy depletion in depression with somatization.

Ann Gardner, Richard G Boles.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18230947     DOI： 10.1159/000112891

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN： 0033-3190            Impact factor:   17.659


× No keyword cloud information.
  13 in total

Review 1.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

Review 2.  Evolution in the Understanding of Autism Spectrum Disorder: Historical Perspective.

Authors:  Mark Mintz
Journal:  Indian J Pediatr       Date:  2016-04-07       Impact factor: 1.967

Review 3.  Sex-dependent mental illnesses and mitochondria.

Authors:  Akiko Shimamoto; Virginie Rappeneau
Journal:  Schizophr Res       Date:  2017-03-06       Impact factor: 4.939

4.  Irritable bowel syndrome may be associated with maternal inheritance and mitochondrial DNA control region sequence variants.

Authors:  Miranda A L van Tilburg; Essam A Zaki; Thangam Venkatesan; Richard G Boles
Journal:  Dig Dis Sci       Date:  2014-02-06       Impact factor: 3.199

5.  Symptoms of somatization as a rapid screening tool for mitochondrial dysfunction in depression.

Authors:  Ann Gardner; Richard G Boles
Journal:  Biopsychosoc Med       Date:  2008-02-22

6.  Effect of Xiaoyaosan on major depressive disorder.

Authors:  Lin-Lin Jing; Xiao-Xia Zhu; Zhi-Ping Lv; Xue-Gang Sun
Journal:  Chin Med       Date:  2015-07-19       Impact factor: 5.455

Review 7.  Psychiatric Disorders and Polyphenols: Can They Be Helpful in Therapy?

Authors:  Jana Trebatická; Zdeňka Ďuračková
Journal:  Oxid Med Cell Longev       Date:  2015-06-09       Impact factor: 6.543

Review 8.  Resilience Dysregulation in Major Depressive Disorder: Focus on Glutamatergic Imbalance and Microglial Activation.

Authors:  Gislaine Z Reus; Airam B de Moura; Ritele H Silva; Wilson R Resende; Joao Quevedo
Journal:  Curr Neuropharmacol       Date:  2018-03-05       Impact factor: 7.363

9.  Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder.

Authors:  Brandi Rollins; Maureen V Martin; P Adolfo Sequeira; Emily A Moon; Ling Z Morgan; Stanley J Watson; Alan Schatzberg; Huda Akil; Richard M Myers; Edward G Jones; Douglas C Wallace; William E Bunney; Marquis P Vawter
Journal:  PLoS One       Date:  2009-03-17       Impact factor: 3.240

10.  Therapeutic Targets and Mechanism of Xingpi Jieyu Decoction in Depression: A Network Pharmacology Study.

Authors:  Ze Chang; Li-Juan He; Dang-Feng Tian; Qiang Gao; Jing-Feng Ling; Yu-Chun Wang; Zhen-Yun Han; Rong-Juan Guo
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-23       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.